DB Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$117K Hold
200
0.07% 111
2023
Q3
$107K Hold
200
0.07% 109
2023
Q2
$93.8K Hold
200
0.06% 110
2023
Q1
$68.7K Hold
200
0.04% 132
2022
Q4
$73.2K Hold
200
0.05% 122
2022
Q3
$65K Hold
200
0.05% 130
2022
Q2
$65K Hold
200
0.04% 137
2022
Q1
$57K Hold
200
0.03% 161
2021
Q4
$55K Hold
200
0.03% 157
2021
Q3
$46K Hold
200
0.03% 164
2021
Q2
$46K Hold
200
0.03% 164
2021
Q1
$37K Hold
200
0.03% 179
2020
Q4
$34K Buy
+200
New +$29.9K 0.03% 178

Other funds holding LLY

DB Wealth Management Group's LLY Position: Q4 2023 in Review

DB Wealth Management Group held its Eli Lilly (LLY) position steady in Q4 2023 at 200 shares worth $117K. The position accounts for 0.07% of the portfolio, ranked #111.

DB Wealth Management Group first reported a position in LLY in Q4 2020 and has held it in 13 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • DB Wealth Management Group held 200 shares of Eli Lilly worth $117K as of Q4 2023.
  • DB Wealth Management Group left its Eli Lilly share count unchanged in Q4 2023.
  • Eli Lilly made up 0.07% of DB Wealth Management Group's portfolio in Q4 2023, its #111 holding.
  • DB Wealth Management Group first reported a position in Eli Lilly in Q4 2020 and has held it in 13 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.